News & Updates

RELIEVE-AD: Atopic dermatitis patients see rapid, sustained improvements with dupilumab
RELIEVE-AD: Atopic dermatitis patients see rapid, sustained improvements with dupilumab
17 Jun 2022 byJairia Dela Cruz

The biologic dupilumab appears to be a hit with atopic dermatitis (AD) patients treated in the real-world setting, with patients experiencing prompt improvements in multiple aspects of disease control that persisted through 1 year, as shown in the results of the RELIEVE-AD* study.

RELIEVE-AD: Atopic dermatitis patients see rapid, sustained improvements with dupilumab
17 Jun 2022
Tradition, conditioning influence parental perceptions of GERD in Asian infants
Tradition, conditioning influence parental perceptions of GERD in Asian infants
17 Jun 2022 byStephen Padilla

In the first 3 months of a newborn’s life, the prevalence of gastroesophageal reflux disease (GERD) is at its peak, but most infants outgrow it by age 1 year, according to a Singapore study, noting that those breastfed at 3 weeks have a lower likelihood of GERD.

Tradition, conditioning influence parental perceptions of GERD in Asian infants
17 Jun 2022
Belt-type device slows breathing rate to ease test anxiety in students
Belt-type device slows breathing rate to ease test anxiety in students
17 Jun 2022
Antihistamines potentially beneficial for knee OA
Antihistamines potentially beneficial for knee OA
17 Jun 2022